EDITORIAL
Published on 17 Oct 2024
Editorial: Antiviral options for emerging and reemerging viral diseases: current therapeutics, novel drug candidates and new approaches
doi 10.3389/fcimb.2024.1497018
- 489 views
- Frontiers in Cellular and Infection Microbiology
- Molecular Viral Pathogenesis
- Research Topics
- Antiviral options for emerging and reemerging viral diseases: Current therapeutics, novel drug candidates and new approaches
Antiviral options for emerging and reemerging viral diseases: Current therapeutics, novel drug candidates and new approaches
10k
Total downloads
36k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
REVIEW
Published on 26 Jun 2024
Advances in virus-like particle-based SARS-CoV-2 vaccines
doi 10.3389/fcimb.2024.1406091
- 1,507 views
- 1 citation
ORIGINAL RESEARCH
Published on 25 Apr 2024
Rutin prevents EqHV-8 induced infection and oxidative stress via Nrf2/HO-1 signaling pathway
doi 10.3389/fcimb.2024.1386462
- 1,024 views
- 3 citations
ORIGINAL RESEARCH
Published on 04 Mar 2024
Identifying potential monkeypox virus inhibitors: an in silico study targeting the A42R protein
doi 10.3389/fcimb.2024.1351737
- 4,645 views
- 1 citation
REVIEW
Published on 21 Feb 2024
Natural products as a source of Coronavirus entry inhibitors
doi 10.3389/fcimb.2024.1353971
- 3,457 views
- 1 citation
REVIEW
Published on 29 Nov 2023
Antiviral options and therapeutics against influenza: history, latest developments and future prospects
doi 10.3389/fcimb.2023.1269344
- 5,243 views
- 5 citations
ORIGINAL RESEARCH
Published on 26 Oct 2023
Influenza A virus replication has a stronger dependency on Raf/MEK/ERK signaling pathway activity than SARS-CoV-2
doi 10.3389/fcimb.2023.1264983
- 2,225 views
- 2 citations
REVIEW
Published on 25 Oct 2023
Role of Tau protein in long COVID and potential therapeutic targets
doi 10.3389/fcimb.2023.1280600
- 10,714 views
- 4 citations
Published in
Frontiers in Cellular and Infection Microbiology
- Molecular Viral Pathogenesis
Impact
- 36kTopic views
- 25kArticle views
- 10kArticle downloads